As Gami­da Cell eyes its first cell ther­a­py ap­proval, Ju­lian Adams is head­ing out

Ju­lian Adams didn’t ex­act­ly fin­ish what he set out to do at Gami­da Cell, but it seems like he got close enough.

The sea­soned biotech ex­ec — who ce­ment­ed his rep­u­ta­tion at Mil­len­ni­um and then In­fin­i­ty — is step­ping down and pass­ing the ba­ton to Abi­gail Jenk­ins just af­ter he steered the com­pa­ny to­ward its first BLA fil­ing for a cell ther­a­py. Gami­da Cell is call­ing it a re­tire­ment, if that word still holds any weight in this in­dus­try.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER